Neurology® Podcast

In this insightful discussion, Janis Miyasaki, a neurology division director and palliative care advocate, shares her journey and the importance of patient-centered approaches in integrating palliative care into neurology. Miranda Wan, a stroke fellow, reveals barriers neurologists face in conversations about palliative care, emphasizing cultural and training deficiencies. Carolyn Reynolds, a palliative care physician, examines the motivations of ALS patients considering medical aid in dying, highlighting emotional suffering and the critical role of caregivers. This dialogue sparks vital reflections on compassionate end-of-life care.

Dr. Alex Menze talks with Professor Hakan Cetin about the need to reevaluate the approach to diagnosing and treating seronegative myasthenia gravis. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

Dr. Gregg Day talks with Professor Jonathan Rohrer about the significance of studying individuals at risk of developing genetic frontotemporal dementia, focusing on how early cognitive changes before symptoms appear can inform research and future therapeutic trials. Read the related article in Neurology®Genetics. Disclosures can be found at Neurology.org.

Dr. YuHong Fu, a neuroscientist from the University of Sydney, dives into the critical distinctions between dementia with Lewy bodies and Parkinson disease dementia. She highlights the unique clinical symptoms, such as fluctuating attention and hallucinations in DLB. Fu discusses how understanding these differences not only aids in diagnosis but also influences treatment strategies. She touches on biomarkers like DaT scans and emerging assays, emphasizing their roles in tailoring personalized care for patients.

Dr. Dan Ackerman talks with Dr. Isabel Hostettler about the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

In a special episode of the Neurology Podcast, Dr. Stacey Clardy discusses how AI is shaping various aspects of our lives, including podcasts. Read the related article in Neurology® Open Access. Disclosures can be found at Neurology.org.

Dr. Matthew Ryan Woodward, a Neurointensivist at the University of Maryland, dives deep into the complexities of status epilepticus. He discusses the critical transition to refractory and super-refractory states, shedding light on treatment implications. Matthew reveals insights from an international survey on real-world management variability, highlighting differences in diagnostics and prognostication. The conversation also touches on ableism in healthcare and strategies for better multidisciplinary collaboration in treatment practices.

Dr. Stacey Clardy talks with Dr. Sandra Vukusic about the disparities in treatment for female patients with multiple sclerosis, particularly focusing on how pregnancy influences treatment decisions and the overall lower exposure to disease-modifying therapies in women compared to men. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

Dr. Alison Christy talks with Dr. Jennifer L. McGuire about neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

The November 2025 Recall revisits four insightful episodes centered on muscle and neuromuscular diseases. Kicking off the episode is a two-part series on myositis, where Dr. Stacey Clardy speaks with Dr. Andrew Mammen. The episode continues with an interview featuring Dr. Eric Voorn, who discusses the effectiveness of combining personalized, home-based aerobic exercise with coaching to improve physical fitness in individuals with neuromuscular diseases. The episode wraps up with Dr. Elia Sechi discussing the critical role of interpreting lab test results, understanding assay performance, and recognizing the real-world impact of false positives in myasthenia gravis diagnostics. Podcast links: Updates on All Things Myositis – Part 1 Updates on All Things Myositis - Part 2 Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice Article links: Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice Show citations: Oorschot S, Brehm MA, van Groenestijn AC, et al. Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases: A Randomized Clinical Trial. Neurology. 2025;105(1):e213781. doi:10.1212/WNL.0000000000213781 Zara P, Chessa P, Deiana GA, et al. Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice. Neurology. 2025;104(9):e213498. doi:10.1212/WNL.0000000000213498 Disclosures can be found at Neurology.org.